In regulatory news:

The FDA has issued five draft documents related to drug compounding and repackaging to help entities comply with important public health provisions. The draft documents are applicable to pharmacies, federal facilities, outsourcing facilities and physicians and cover how and why certain entities must register as outsourcing facilities, mixing and diluting biologics, and state/federal distribution distinctions.

Read the release and access the documents via Workers’ Compensation Institute 360 here.

Leave a Comment

Your email address will not be published. Required fields are marked *